Roche Holding AG (OTC:RHHBY) is ramping up its artificial intelligence capabilities with a large-scale AI "factory" powered by advanced computing from NVIDIA Corp. (NASDAQ:NVDA), aiming to accelerate drug development timelines and improve diagnostics across its global operations.

Roche Expands AI Infrastructure Across US And Europe

The Swiss pharmaceutical giant on Monday said the new infrastructure includes 2,176 high-performance GPUs deployed on premises across the U.S. and Europe.

Combined with its cloud capabilities, Roche's total AI computing capacity now exceeds 3,500 Blackwell GPUs, marking one of the largest AI footprints disclosed by a pharmaceutical company.

The initiative builds on a strategic collaboration with NVIDIA that began in 2023, reflecting Roche's push to integrate AI across its full value chain,